Literature DB >> 18848136

Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.

Pedro R Moreno1, K Raman Purushothaman, Meera Purushothaman, Paul Muntner, Nina S Levy, Valentin Fuster, John T Fallon, Patrick A Lento, Aaron Winterstern, Andrew P Levy.   

Abstract

OBJECTIVES: We sought to test the hypothesis that haptoglobin (Hp) genotype is a determinant of the amount of iron in the atherosclerotic plaque.
BACKGROUND: In atherosclerotic lesions, intraplaque hemorrhage releases free hemoglobin (Hb), whose incorporated iron can act as an oxidant and inflammatory stimulus. These effects are antagonized by Hp, which binds free Hb and facilitates its clearance from the plaque. The Hp gene has 2 alleles (1 and 2), giving rise to 3 genotypes: Hp 1-1, Hp 2-1, and Hp 2-2. We previously hypothesized that Hp 2-2 individuals with diabetes mellitus (DM) have impaired clearance of Hb and its iron cargo from the plaque.
METHODS: We identified the presence or absence of Perl's iron stain in 189 plaques obtained from 37 decedents at autopsy.
RESULTS: Among DM, the prevalence of Perl's iron stain was increased in Hp 2-2 compared with that seen in Hp 1-1 or 2-1 (46.2% vs. 11.8%). After accounting for the within-decedent correlation of plaques, the prevalence ratio of Perl's iron stain associated with Hp 2-2 was 3.97 (95% confidence interval: 1.38 to 11.5; p = 0.025). In non-DM plaques, there was a nonsignificant trend towards a higher prevalence of iron staining in Hp 2-2 compared with that in Hp 1-1 or 2-1 (26.8% vs. 11.1%; prevalence ratio =2.40 [95% confidence interval: 0.81 to 7.09]; p = 0.114).
CONCLUSIONS: These data support an impaired clearance of Hb from plaques in Hp 2-2 individuals, particularly in DM. The higher prevalence of plaque iron in Hp 2-2 DM individuals may contribute to the increased incidence of atherothrombotic events in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848136     DOI: 10.1016/j.jacc.2008.06.029

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

Review 1.  Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors:  Tina Costacou; Andrew P Levy
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

2.  Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors:  Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

3.  Haptoglobin genotype and the iron hypothesis of atherosclerosis.

Authors:  Hilla Lee Viener; Andrew P Levy
Journal:  Atherosclerosis       Date:  2011-01-28       Impact factor: 5.162

4.  Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.

Authors:  Miriam Lipiski; Jeremy W Deuel; Jin Hyen Baek; Wolfgang R Engelsberger; Paul W Buehler; Dominik J Schaer
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 5.  Haptoglobin genotype and its role in determining heme-iron mediated vascular disease.

Authors:  Hagit Goldenstein; Nina S Levy; Andrew P Levy
Journal:  Pharmacol Res       Date:  2012-03-23       Impact factor: 7.658

6.  Ipsilateral plaques display higher T1 signals than contralateral plaques in recently symptomatic patients with bilateral carotid intraplaque hemorrhage.

Authors:  Xianling Wang; Jie Sun; Xihai Zhao; Daniel S Hippe; Thomas S Hatsukami; Jin Liu; Rui Li; Gador Canton; Yan Song; Chun Yuan
Journal:  Atherosclerosis       Date:  2017-01-12       Impact factor: 5.162

7.  Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.

Authors:  Hilla-Lee Veiner; Rostic Gorbatov; Moshe Vardi; Gheorghe Doros; Rachel Miller-Lotan; Yaniv Zohar; Edmond Sabo; Rabea Asleh; Nina S Levy; Levi J Goldfarb; Thomas A Berk; Tali Haas; Hadar Shalom; Edith Suss-Toby; Adi Kam; Marielle Kaplan; Ronit Tamir; Anna Ziskind; Andrew P Levy
Journal:  Atherosclerosis       Date:  2015-01-14       Impact factor: 5.162

8.  The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Authors:  Shiri Kalet-Litman; Pedro R Moreno; Andrew P Levy
Journal:  Atherosclerosis       Date:  2009-09-06       Impact factor: 5.162

9.  Poor lysosomal membrane integrity in proximal tubule cells of haptoglobin 2-2 genotype mice with diabetes mellitus.

Authors:  Rabea Asleh; Farid M Nakhoul; Rachel Miller-Lotan; Hoda Awad; Dan Farbstein; Nina S Levy; Nakhoul Nakhoul; Theodore C Iancu; Irena Manov; Michael Laue; Maret G Traber; Katie M Lebold; Andrew P Levy
Journal:  Free Radic Biol Med       Date:  2012-06-27       Impact factor: 7.376

Review 10.  Iron and atherosclerosis: nailing down a novel target with magnetic resonance.

Authors:  Travis P Sharkey-Toppen; Arun K Tewari; Subha V Raman
Journal:  J Cardiovasc Transl Res       Date:  2014-03-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.